There is increasing evidence that malignant tumors are initiated and maintained by a sub-
population of tumor cells that have similar biological properties to normal adult stem cells …

Despite significant treatment advances, breast cancer remains the leading cause of cancer
death in women. From the current treatment situation, in addition to developing …

Background Management of triple-negative breast cancer (TNBC) is still challenging
because of its aggressive clinical behavior and limited targeted treatment options. Cisplatin …

Breast cancer (BC) is the most common malignancy in women worldwide. It is a very
heterogeneous disease characterized by different molecular profiles that are clinically …

Small interfering RNA (siRNA) therapies require effective delivery vehicles capable of
carrying the siRNA cargo into target cells. To achieve tumor-targeting, a drug delivery …

Background Triple-negative breast cancer (TNBC) is a uniquely aggressive cancer with high
rates of relapse due to resistance to chemotherapy. TNBC expresses higher levels of …

Photodynamic therapy (PDT) may be an excellent alternative in the treatment of breast
cancer, mainly for the most aggressive type with limited targeted therapies such as triple …

The identification of tumor cell-specific surface markers is a key step towards personalized
cancer medicine, allowing early assessment and accurate diagnosis, and development of …

Triple-negative breast cancer (TNBC) is among the most aggressive breast cancer subtypes.
Despite being initially responsive to chemotherapy, patients develop drug-resistant and …

Despite improvements in B cell acute lymphoblastic leukemia (B-ALL) treatment, a
significant number of patients experience relapse of the disease, resulting in poor prognosis …